Published in Breast Cancer Res Treat on August 28, 2014
Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective study. Virchows Arch (2016) 0.78
Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer. J Clin Med Res (2015) 0.78
Sentinel lymph nodes for breast carcinoma: an update on current practice. Histopathology (2016) 0.75
A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients. PLoS One (2017) 0.75
Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study. Mol Clin Oncol (2016) 0.75
Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma. J Transl Med (2017) 0.75
Sentinel Lymph Nodes for Breast Carcinoma: A Paradigm Shift. Arch Pathol Lab Med (2016) 0.75
One-step nucleic acid amplification (OSNA): where do we go with it? Int J Clin Oncol (2016) 0.75
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res (2008) 6.95
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol (2012) 2.70
Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res (2006) 2.34
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res (2006) 2.15
Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat (2006) 2.10
Angiogenesis and ovarian cancer. Clin Transl Oncol (2009) 2.09
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol (2007) 2.09
USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat Med (2012) 1.93
Adenomatoid tumors of the uterus: an analysis of 60 cases. Int J Gynecol Pathol (2002) 1.80
Cyclin D1 gene (CCND1) mutations in endometrial cancer. Oncogene (2003) 1.74
The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer (2010) 1.73
Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res (2009) 1.68
Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study. Diagn Mol Pathol (2012) 1.56
Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas. Cancer Res (2008) 1.48
Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene (2002) 1.46
Inactivation of the candidate tumor suppressor par-4 in endometrial cancer. Cancer Res (2007) 1.45
Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis (2005) 1.44
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer (2003) 1.43
Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene (2004) 1.39
An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer. BMC Cancer (2010) 1.34
Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues. Biotechniques (2010) 1.31
Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas. EMBO Mol Med (2011) 1.28
Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas. J Clin Pathol (2006) 1.20
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J Pathol (2014) 1.19
Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res Treat (2006) 1.12
Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res (2003) 1.11
miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9. PLoS One (2013) 1.09
Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol (2003) 1.04
Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas. Hum Pathol (2006) 1.04
A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-positive breast cancers. Cancer Res (2010) 1.02
Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma. J Pathol (2003) 1.02
Diagnosis of the sentinel lymph node in breast cancer: a reproducible molecular method: a multicentric Spanish study. Histopathology (2011) 0.98
Aurora kinases as prognostic biomarkers in ovarian carcinoma. Hum Pathol (2009) 0.97
DNA methylation signatures identify biologically distinct thyroid cancer subtypes. J Clin Endocrinol Metab (2013) 0.92
The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model. Int J Oncol (2011) 0.92
Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Clin Transl Oncol (2008) 0.92
Lymphatic mapping could not be impaired in the presence of breast carcinoma and coexisting small lymphocytic lymphoma. Am J Case Rep (2013) 0.91
The PTEN/NRF2 axis promotes human carcinogenesis. Antioxid Redox Signal (2014) 0.90
Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum Pathol (2009) 0.90
Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors. Int J Cancer (2004) 0.89
Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2. J Clin Invest (2013) 0.87
Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer. PLoS One (2009) 0.86
Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy. Cancer Cytopathol (2014) 0.85
Molecular alterations associated with cyclin D1 overexpression in endometrial cancer. Int J Cancer (2004) 0.85
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations. Mol Cancer (2014) 0.83
Low frequency of BRAF mutations in endometrial and in cervical carcinomas. Clin Cancer Res (2006) 0.82
Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma. PLoS One (2008) 0.82
Renin angiotensin system-regulating aminopeptidase activities in serum of pre- and postmenopausal women with breast cancer. Breast (2011) 0.82
Insulin-regulated aminopeptidase/placental leucil Aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea. Anticancer Res (2006) 0.81
Pathological findings in the complete trisomy 9 syndrome: three case reports and review of the literature. Pediatr Dev Pathol (2008) 0.81
Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis. Breast (2012) 0.81
Eccrine porocarcinoma (malignant eccrine poroma). Am J Surg Pathol (2002) 0.81
Aurora B kinase expression in laryngeal squamous cell carcinoma and its prognostic implications. Histopathology (2011) 0.81
Serum enkephalin-degrading aminopeptidase activity in N-methyl nitrosourea-induced rat breast cancer. Anticancer Res (2005) 0.80
Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen. Mod Pathol (2008) 0.79
Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer. J Surg Oncol (2012) 0.79
Neoadjuvant chemotherapy modifies serum angiotensinase activities in women with breast cancer. Maturitas (2012) 0.78
Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification. Histopathology (2013) 0.77
Histopathological analysis of human specimens removed from the injection area of expanded adipose-derived stem cells. Histopathology (2010) 0.77
Intraoperative assessment of sentinel lymph nodes after neoadjuvant chemotherapy in patients with breast cancer. Ann Surg Oncol (2009) 0.77
NIS mediates iodide uptake in the female reproductive tract and is a poor prognostic factor in ovarian cancer. J Clin Endocrinol Metab (2014) 0.76
mRNA in situ hybridization (HistoSonda): a new diagnostic tool for HER2-status in breast cancer-a multicentric Spanish study. Diagn Mol Pathol (2012) 0.76
Breast metastasis from rhabdomyosarcoma of the nasal septum in a pregnant adult woman. Breast J (2011) 0.76
Putative relationship between hormonal status and serum pyrrolidone carboxypeptidase activity in pre- and post- menopausal women with breast cancer. Breast (2012) 0.75
Subclassification of the molecular types of breast cancer based on the expression of immunohistochemical markers and evolution. Invest Clin (2016) 0.75
From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer. Expert Opin Investig Drugs (2011) 0.75
ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity. Sci Rep (2015) 0.75
Safety and efficacy of neo-adjuvant sequential dose-dense chemotherapy doublets combined with trastuzumab in patients with HER-2-positive early stage breast cancer. Breast J (2008) 0.75
[Cadherins E and P expression in the molecular types of breast cancer]. Invest Clin (2015) 0.75
Multiple pulmonary leiomyomatous hamartomas associated with a bronchogenic cyst in a man. Arch Pathol Lab Med (2003) 0.75
Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation: a clinicopathologic study of 5 cases and review of the literature. Hum Pathol (2008) 0.75
Surgery improves breast cancer-specific survival in octogenarians with early-stage breast cancer. Int J Surg (2013) 0.75